Skip to content

ACRO Biomedical Co Ltd Sustainability Reports

ACRO Biomedical Co., Ltd. develops and manufactures medical-grade regenerative biomaterials derived from animal tissue. Its product pipeline specializes in human tissue engineering, regenerative medicine, wound care, orthopedics, dentistry, and ophthalmology.

Sector: Manufacturing

Country: Taiwan

Exchange: Taipei Exchange

FIGI: BBG00BCHW213

4 reports from 2019 to 2024